Topoisomerase inhibitor, Idarubicin HCl, Purity ≥98%

Cat. No.: X24-08-YM017

Topoisomerase inhibitor, Idarubicin HCl, Purity ≥98%

Synonym: 57852-57-0; Idamycin; Zavedos; 4-Demethoxydaunorubicin; DMDR; IMI-30; (7S,9S)-9-Acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione; hydrochloride

  • MDL: MFCD00866457
  • CAS Number: 57852-57-0
  • Compound CID: 636362
Product Size
5 mg; 10 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
Idarubicin HCl, soluble in DMSO and warmed water and insoluble in ethanol, is an effective DNA damage inhibitor, that has the ability to prevent the pathway of DNA damage by inhibiting topoisomerase. It targets the multicellular spheroids (cell-free assay) and Topo II (MCF-7 cells) (cell-free assay).
Molecular Weight
534
Molecular Formula
C26H28ClNO9
Targets
Multicellular spheroids (Cell-free assay): 7.9 ng/mL; Topo II (MCF-7 cells) (Cell-free assay): 3.3 ng/mL
Form
Lyophilized powder
Purity
≥98%
Titer
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects
Solubility
In vitro: DMSO: 88 mg/mL (164.81 mM); Water (warmed): 4 mg/mL (7.49 mM); Ethanol: insoluble
Stability
In its lyophilized form, the chemical remains stable for 36 months.
Quality Level
Research grade
Applications
Idarubicin HCl is a DNA damage inhibitor that plays a key role in inhibiting topoisomerase II and inducing oxidative stress, which leads to cell death.
Storage
Store at -20ºC, and keep desiccated.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.